BOTZ stock forecast 2030 may benefit from EU investments in AI tools, which could increase demand for automation suppliers counted in BOTZ’s basket. Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services in Medical and Surgical, Neurotechnology, Orthopedics, and Spine. Its robotics arm, Mako, develops spinal and knee devices, among other products. Stryker also specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows. The company assists surgeons in visualizing and reviewing patients via Apple Vision Pro. Some of its top holdings include Nvidia, Intuitive Surgical (NASDAQ: ISRG ), SMC Corporation (OTCMKTS: SMCAY ), iRobot Corporation (NASDAQ;IRBT), and Accuray (NASDAQ: ARAY ). While the BOTZ chart has seen better days, give it time. Much of the recent tech rout and negativity has already been priced in. Now, as this ETF starts to perk back up, I’d like to see the ETF break above resistance around $24 and test the $30 level. BOTZ stock forecast 2030 could benefit from rising defense and aerospace automation budgets as geopolitical pressures intensify in the late 2020s.